MediWound Ltd. (NASDAQ:MDWD) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Key Points

• MediWound Ltd. (NASDAQ:MDWD) has received a consensus rating of "Moderate Buy" from analysts, with one hold rating and four buy recommendations.
• The average twelve-month price target for MediWound shares is $32.25, with recent prices ranging from $14.14 to $22.50.
• In its latest quarterly earnings report, MediWound reported an EPS of (\$1.23), missing the estimated consensus of (\$0.55), though revenue slightly exceeded expectations at $5.71 million.

MediWound Ltd. (NASDAQ:MDWD - Get Free Report) has earned a consensus rating of "Moderate Buy" from the five ratings firms that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $32.25.

MDWD has been the subject of a number of recent analyst reports. HC Wainwright set a $31.00 price target on shares of MediWound and gave the company a "buy" rating in a report on Thursday, May 22nd. Oppenheimer started coverage on shares of MediWound in a report on Monday, June 2nd. They set an "outperform" rating and a $34.00 price target for the company. Wall Street Zen lowered shares of MediWound from a "hold" rating to a "sell" rating in a report on Friday, July 18th. Finally, Zacks Research lowered shares of MediWound from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, August 19th.

Institutional Trading of MediWound

Institutional investors have recently bought and sold shares of the company. Northern Trust Corp boosted its holdings in shares of MediWound by 94.6% during the 4th quarter. Northern Trust Corp now owns 144,768 shares of the biopharmaceutical company's stock valued at $2,577,000 after acquiring an additional 70,367 shares during the last quarter. Silverberg Bernstein Capital Management LLC boosted its holdings in shares of MediWound by 41.9% in the second quarter. Silverberg Bernstein Capital Management LLC now owns 147,535 shares of the biopharmaceutical company's stock worth $2,858,000 after buying an additional 43,591 shares during the last quarter. Menora Mivtachim Holdings LTD. purchased a new position in shares of MediWound in the second quarter worth approximately $339,000. Marshall Wace LLP purchased a new position in shares of MediWound in the second quarter worth approximately $317,000. Finally, Jane Street Group LLC purchased a new position in shares of MediWound in the second quarter worth approximately $295,000. 46.83% of the stock is owned by hedge funds and other institutional investors.

MediWound Price Performance

MDWD stock opened at $17.84 on Monday. MediWound has a one year low of $14.14 and a one year high of $22.50. The stock has a market cap of $192.81 million, a PE ratio of -6.76 and a beta of 0.25. The firm has a 50 day simple moving average of $18.58 and a two-hundred day simple moving average of $18.45.

MediWound (NASDAQ:MDWD - Get Free Report) last released its quarterly earnings results on Thursday, August 14th. The biopharmaceutical company reported ($1.23) EPS for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.68). MediWound had a negative return on equity of 96.71% and a negative net margin of 142.18%.The company had revenue of $5.71 million during the quarter, compared to analysts' expectations of $5.68 million. On average, research analysts expect that MediWound will post -2.66 EPS for the current fiscal year.

MediWound Company Profile

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in United States, Europe, and internationally. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.